カテゴリ： QYResearch, 世界, 医療/バイオ

アリピプラゾールAPIの世界市場2023年：純度≧99%、純度＜99%

■ 英語タイトル：Global Aripiprazole API Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8680）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8680
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アリピプラゾールAPIの世界市場2023年：純度≧99%、純度＜99%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はアリピプラゾールAPIのグローバル市場について調査・分析し、世界のアリピプラゾールAPI市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（純度≧99%、純度＜99%）、用途別セグメント分析（錠剤、内服液、ODT、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Teva、APOTEX、SMS Pharmaceutical、Otsuka Pharmaceutical、Bal Pharma、Huahai Pharmaceutical、Jiuzhou Pharmaceutical、Qilu Pharmaceutical、Yangtze River Pharmaceutical、Kanghong Pharmaceutical、Yongtai Pharmaceuticalなどが含まれています。アリピプラゾールAPIのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、アリピプラゾールAPI市場規模を算出する際に考慮しました。

・アリピプラゾールAPI市場の概要
- 製品の定義
- アリピプラゾールAPIの種類別セグメント
- 世界のアリピプラゾールAPI市場規模：タイプ別分析（純度≧99%、純度＜99%）
- アリピプラゾールAPIの用途別セグメント
- 世界のアリピプラゾールAPI市場規模：用途別分析（錠剤、内服液、ODT、その他）
- 世界のアリピプラゾールAPI市場規模予測（2018年-2029年）
- アリピプラゾールAPIの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- アリピプラゾールAPI市場の競争状況およびトレンド

・アリピプラゾールAPIの地域別市場規模
- 北米のアリピプラゾールAPI市場規模（2018年-2029年）
- 米国のアリピプラゾールAPI市場規模（2018年-2029年）
- ヨーロッパのアリピプラゾールAPI市場規模（2018年-2029年）
- アジア太平洋のアリピプラゾールAPI市場規模（2018年-2029年）
- 中国のアリピプラゾールAPI市場規模（2018年-2029年）
- 日本のアリピプラゾールAPI市場規模（2018年-2029年）
- 韓国のアリピプラゾールAPI市場規模（2018年-2029年）
- インドのアリピプラゾールAPI市場規模（2018年-2029年）
- オーストラリアのアリピプラゾールAPI市場規模（2018年-2029年）
- 中南米のアリピプラゾールAPI市場規模（2018年-2029年）
- 中東・アフリカのアリピプラゾールAPI市場規模（2018年-2029年）

・種類別セグメント：純度≧99%、純度＜99%
- 世界のアリピプラゾールAPIのタイプ別販売量（2018年-2023年）
- 世界のアリピプラゾールAPIのタイプ別売上（2018年-2023年）
- 世界のアリピプラゾールAPIのタイプ別価格

・用途別セグメント：錠剤、内服液、ODT、その他
- 世界のアリピプラゾールAPIの用途別販売量（2018年-2023年）
- 世界のアリピプラゾールAPIの用途別売上（2018年-2023年）
- 世界のアリピプラゾールAPIの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Teva、APOTEX、SMS Pharmaceutical、Otsuka Pharmaceutical、Bal Pharma、Huahai Pharmaceutical、Jiuzhou Pharmaceutical、Qilu Pharmaceutical、Yangtze River Pharmaceutical、Kanghong Pharmaceutical、Yongtai Pharmaceutical

・産業チェーンと販売チャネルの分析
- アリピプラゾールAPI産業チェーン分析
- アリピプラゾールAPIの主要原材料
- アリピプラゾールAPIの販売チャネル
- アリピプラゾールAPIのディストリビューター
- アリピプラゾールAPIの主要顧客

・アリピプラゾールAPI市場ダイナミクス
- アリピプラゾールAPIの業界動向
- アリピプラゾールAPI市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Aripiprazole API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Aripiprazole API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Aripiprazole API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Aripiprazole API include Teva, APOTEX, SMS Pharmaceutical, Otsuka Pharmaceutical, Bal Pharma, Huahai Pharmaceutical, Jiuzhou Pharmaceutical, Qilu Pharmaceutical and Yangtze River Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aripiprazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aripiprazole API.
The Aripiprazole API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Aripiprazole API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aripiprazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Teva
APOTEX
SMS Pharmaceutical
Otsuka Pharmaceutical
Bal Pharma
Huahai Pharmaceutical
Jiuzhou Pharmaceutical
Qilu Pharmaceutical
Yangtze River Pharmaceutical
Kanghong Pharmaceutical
Yongtai Pharmaceutical
Segment by Type
Purity ≥ 99%
Purity ＜99%
Segment by Application
Tablets
Oral Solution
ODT
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aripiprazole API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aripiprazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Aripiprazole API Market Overview
1.1 Product Overview and Scope of Aripiprazole API
1.2 Aripiprazole API Segment by Type
1.2.1 Global Aripiprazole API Market Value Comparison by Type (2023-2029)
1.2.2 Purity ≥ 99%
1.2.3 Purity ＜99%
1.3 Aripiprazole API Segment by Application
1.3.1 Global Aripiprazole API Market Value by Application: (2023-2029)
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 ODT
1.3.5 Others
1.4 Global Aripiprazole API Market Size Estimates and Forecasts
1.4.1 Global Aripiprazole API Revenue 2018-2029
1.4.2 Global Aripiprazole API Sales 2018-2029
1.4.3 Global Aripiprazole API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Aripiprazole API Market Competition by Manufacturers
2.1 Global Aripiprazole API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aripiprazole API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aripiprazole API Average Price by Manufacturers (2018-2023)
2.4 Global Aripiprazole API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Aripiprazole API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aripiprazole API, Product Type & Application
2.7 Aripiprazole API Market Competitive Situation and Trends
2.7.1 Aripiprazole API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aripiprazole API Players Market Share by Revenue
2.7.3 Global Aripiprazole API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aripiprazole API Retrospective Market Scenario by Region
3.1 Global Aripiprazole API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aripiprazole API Global Aripiprazole API Sales by Region: 2018-2029
3.2.1 Global Aripiprazole API Sales by Region: 2018-2023
3.2.2 Global Aripiprazole API Sales by Region: 2024-2029
3.3 Global Aripiprazole API Global Aripiprazole API Revenue by Region: 2018-2029
3.3.1 Global Aripiprazole API Revenue by Region: 2018-2023
3.3.2 Global Aripiprazole API Revenue by Region: 2024-2029
3.4 North America Aripiprazole API Market Facts & Figures by Country
3.4.1 North America Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Aripiprazole API Sales by Country (2018-2029)
3.4.3 North America Aripiprazole API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aripiprazole API Market Facts & Figures by Country
3.5.1 Europe Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Aripiprazole API Sales by Country (2018-2029)
3.5.3 Europe Aripiprazole API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aripiprazole API Market Facts & Figures by Country
3.6.1 Asia Pacific Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Aripiprazole API Sales by Country (2018-2029)
3.6.3 Asia Pacific Aripiprazole API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aripiprazole API Market Facts & Figures by Country
3.7.1 Latin America Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Aripiprazole API Sales by Country (2018-2029)
3.7.3 Latin America Aripiprazole API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Aripiprazole API Market Facts & Figures by Country
3.8.1 Middle East and Africa Aripiprazole API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Aripiprazole API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Aripiprazole API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aripiprazole API Sales by Type (2018-2029)
4.1.1 Global Aripiprazole API Sales by Type (2018-2023)
4.1.2 Global Aripiprazole API Sales by Type (2024-2029)
4.1.3 Global Aripiprazole API Sales Market Share by Type (2018-2029)
4.2 Global Aripiprazole API Revenue by Type (2018-2029)
4.2.1 Global Aripiprazole API Revenue by Type (2018-2023)
4.2.2 Global Aripiprazole API Revenue by Type (2024-2029)
4.2.3 Global Aripiprazole API Revenue Market Share by Type (2018-2029)
4.3 Global Aripiprazole API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Aripiprazole API Sales by Application (2018-2029)
5.1.1 Global Aripiprazole API Sales by Application (2018-2023)
5.1.2 Global Aripiprazole API Sales by Application (2024-2029)
5.1.3 Global Aripiprazole API Sales Market Share by Application (2018-2029)
5.2 Global Aripiprazole API Revenue by Application (2018-2029)
5.2.1 Global Aripiprazole API Revenue by Application (2018-2023)
5.2.2 Global Aripiprazole API Revenue by Application (2024-2029)
5.2.3 Global Aripiprazole API Revenue Market Share by Application (2018-2029)
5.3 Global Aripiprazole API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Aripiprazole API Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 APOTEX
6.2.1 APOTEX Corporation Information
6.2.2 APOTEX Description and Business Overview
6.2.3 APOTEX Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 APOTEX Aripiprazole API Product Portfolio
6.2.5 APOTEX Recent Developments/Updates
6.3 SMS Pharmaceutical
6.3.1 SMS Pharmaceutical Corporation Information
6.3.2 SMS Pharmaceutical Description and Business Overview
6.3.3 SMS Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SMS Pharmaceutical Aripiprazole API Product Portfolio
6.3.5 SMS Pharmaceutical Recent Developments/Updates
6.4 Otsuka Pharmaceutical
6.4.1 Otsuka Pharmaceutical Corporation Information
6.4.2 Otsuka Pharmaceutical Description and Business Overview
6.4.3 Otsuka Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Otsuka Pharmaceutical Aripiprazole API Product Portfolio
6.4.5 Otsuka Pharmaceutical Recent Developments/Updates
6.5 Bal Pharma
6.5.1 Bal Pharma Corporation Information
6.5.2 Bal Pharma Description and Business Overview
6.5.3 Bal Pharma Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bal Pharma Aripiprazole API Product Portfolio
6.5.5 Bal Pharma Recent Developments/Updates
6.6 Huahai Pharmaceutical
6.6.1 Huahai Pharmaceutical Corporation Information
6.6.2 Huahai Pharmaceutical Description and Business Overview
6.6.3 Huahai Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Huahai Pharmaceutical Aripiprazole API Product Portfolio
6.6.5 Huahai Pharmaceutical Recent Developments/Updates
6.7 Jiuzhou Pharmaceutical
6.6.1 Jiuzhou Pharmaceutical Corporation Information
6.6.2 Jiuzhou Pharmaceutical Description and Business Overview
6.6.3 Jiuzhou Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiuzhou Pharmaceutical Aripiprazole API Product Portfolio
6.7.5 Jiuzhou Pharmaceutical Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Qilu Pharmaceutical Aripiprazole API Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Yangtze River Pharmaceutical
6.9.1 Yangtze River Pharmaceutical Corporation Information
6.9.2 Yangtze River Pharmaceutical Description and Business Overview
6.9.3 Yangtze River Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Yangtze River Pharmaceutical Aripiprazole API Product Portfolio
6.9.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.10 Kanghong Pharmaceutical
6.10.1 Kanghong Pharmaceutical Corporation Information
6.10.2 Kanghong Pharmaceutical Description and Business Overview
6.10.3 Kanghong Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Kanghong Pharmaceutical Aripiprazole API Product Portfolio
6.10.5 Kanghong Pharmaceutical Recent Developments/Updates
6.11 Yongtai Pharmaceutical
6.11.1 Yongtai Pharmaceutical Corporation Information
6.11.2 Yongtai Pharmaceutical Aripiprazole API Description and Business Overview
6.11.3 Yongtai Pharmaceutical Aripiprazole API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yongtai Pharmaceutical Aripiprazole API Product Portfolio
6.11.5 Yongtai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aripiprazole API Industry Chain Analysis
7.2 Aripiprazole API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aripiprazole API Production Mode & Process
7.4 Aripiprazole API Sales and Marketing
7.4.1 Aripiprazole API Sales Channels
7.4.2 Aripiprazole API Distributors
7.5 Aripiprazole API Customers
8 Aripiprazole API Market Dynamics
8.1 Aripiprazole API Industry Trends
8.2 Aripiprazole API Market Drivers
8.3 Aripiprazole API Market Challenges
8.4 Aripiprazole API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Aripiprazole API Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Aripiprazole API Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Aripiprazole API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Aripiprazole API Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Aripiprazole API Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Aripiprazole API Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Aripiprazole API Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Aripiprazole API Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Aripiprazole API, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Aripiprazole API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aripiprazole API, Product Type & Application
Table 12. Global Key Manufacturers of Aripiprazole API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aripiprazole API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aripiprazole API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aripiprazole API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Aripiprazole API Sales by Region (2018-2023) & (K Units)
Table 18. Global Aripiprazole API Sales Market Share by Region (2018-2023)
Table 19. Global Aripiprazole API Sales by Region (2024-2029) & (K Units)
Table 20. Global Aripiprazole API Sales Market Share by Region (2024-2029)
Table 21. Global Aripiprazole API Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Aripiprazole API Revenue Market Share by Region (2018-2023)
Table 23. Global Aripiprazole API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Aripiprazole API Revenue Market Share by Region (2024-2029)
Table 25. North America Aripiprazole API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Aripiprazole API Sales by Country (2018-2023) & (K Units)
Table 27. North America Aripiprazole API Sales by Country (2024-2029) & (K Units)
Table 28. North America Aripiprazole API Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Aripiprazole API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Aripiprazole API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Aripiprazole API Sales by Country (2018-2023) & (K Units)
Table 32. Europe Aripiprazole API Sales by Country (2024-2029) & (K Units)
Table 33. Europe Aripiprazole API Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Aripiprazole API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Aripiprazole API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Aripiprazole API Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Aripiprazole API Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Aripiprazole API Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Aripiprazole API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Aripiprazole API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Aripiprazole API Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Aripiprazole API Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Aripiprazole API Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Aripiprazole API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Aripiprazole API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Aripiprazole API Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Aripiprazole API Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Aripiprazole API Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Aripiprazole API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Aripiprazole API Sales (K Units) by Type (2018-2023)
Table 51. Global Aripiprazole API Sales (K Units) by Type (2024-2029)
Table 52. Global Aripiprazole API Sales Market Share by Type (2018-2023)
Table 53. Global Aripiprazole API Sales Market Share by Type (2024-2029)
Table 54. Global Aripiprazole API Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Aripiprazole API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Aripiprazole API Revenue Market Share by Type (2018-2023)
Table 57. Global Aripiprazole API Revenue Market Share by Type (2024-2029)
Table 58. Global Aripiprazole API Price (US$/Unit) by Type (2018-2023)
Table 59. Global Aripiprazole API Price (US$/Unit) by Type (2024-2029)
Table 60. Global Aripiprazole API Sales (K Units) by Application (2018-2023)
Table 61. Global Aripiprazole API Sales (K Units) by Application (2024-2029)
Table 62. Global Aripiprazole API Sales Market Share by Application (2018-2023)
Table 63. Global Aripiprazole API Sales Market Share by Application (2024-2029)
Table 64. Global Aripiprazole API Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Aripiprazole API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Aripiprazole API Revenue Market Share by Application (2018-2023)
Table 67. Global Aripiprazole API Revenue Market Share by Application (2024-2029)
Table 68. Global Aripiprazole API Price (US$/Unit) by Application (2018-2023)
Table 69. Global Aripiprazole API Price (US$/Unit) by Application (2024-2029)
Table 70. Teva Corporation Information
Table 71. Teva Description and Business Overview
Table 72. Teva Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Teva Aripiprazole API Product
Table 74. Teva Recent Developments/Updates
Table 75. APOTEX Corporation Information
Table 76. APOTEX Description and Business Overview
Table 77. APOTEX Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. APOTEX Aripiprazole API Product
Table 79. APOTEX Recent Developments/Updates
Table 80. SMS Pharmaceutical Corporation Information
Table 81. SMS Pharmaceutical Description and Business Overview
Table 82. SMS Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. SMS Pharmaceutical Aripiprazole API Product
Table 84. SMS Pharmaceutical Recent Developments/Updates
Table 85. Otsuka Pharmaceutical Corporation Information
Table 86. Otsuka Pharmaceutical Description and Business Overview
Table 87. Otsuka Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Otsuka Pharmaceutical Aripiprazole API Product
Table 89. Otsuka Pharmaceutical Recent Developments/Updates
Table 90. Bal Pharma Corporation Information
Table 91. Bal Pharma Description and Business Overview
Table 92. Bal Pharma Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Bal Pharma Aripiprazole API Product
Table 94. Bal Pharma Recent Developments/Updates
Table 95. Huahai Pharmaceutical Corporation Information
Table 96. Huahai Pharmaceutical Description and Business Overview
Table 97. Huahai Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Huahai Pharmaceutical Aripiprazole API Product
Table 99. Huahai Pharmaceutical Recent Developments/Updates
Table 100. Jiuzhou Pharmaceutical Corporation Information
Table 101. Jiuzhou Pharmaceutical Description and Business Overview
Table 102. Jiuzhou Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Jiuzhou Pharmaceutical Aripiprazole API Product
Table 104. Jiuzhou Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Corporation Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Qilu Pharmaceutical Aripiprazole API Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Yangtze River Pharmaceutical Corporation Information
Table 111. Yangtze River Pharmaceutical Description and Business Overview
Table 112. Yangtze River Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Yangtze River Pharmaceutical Aripiprazole API Product
Table 114. Yangtze River Pharmaceutical Recent Developments/Updates
Table 115. Kanghong Pharmaceutical Corporation Information
Table 116. Kanghong Pharmaceutical Description and Business Overview
Table 117. Kanghong Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Kanghong Pharmaceutical Aripiprazole API Product
Table 119. Kanghong Pharmaceutical Recent Developments/Updates
Table 120. Yongtai Pharmaceutical Corporation Information
Table 121. Yongtai Pharmaceutical Description and Business Overview
Table 122. Yongtai Pharmaceutical Aripiprazole API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Yongtai Pharmaceutical Aripiprazole API Product
Table 124. Yongtai Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Aripiprazole API Distributors List
Table 128. Aripiprazole API Customers List
Table 129. Aripiprazole API Market Trends
Table 130. Aripiprazole API Market Drivers
Table 131. Aripiprazole API Market Challenges
Table 132. Aripiprazole API Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aripiprazole API
Figure 2. Global Aripiprazole API Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Aripiprazole API Market Share by Type in 2022 & 2029
Figure 4. Purity ≥ 99% Product Picture
Figure 5. Purity ＜99% Product Picture
Figure 6. Global Aripiprazole API Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Aripiprazole API Market Share by Application in 2022 & 2029
Figure 8. Tablets
Figure 9. Oral Solution
Figure 10. ODT
Figure 11. Others
Figure 12. Global Aripiprazole API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Aripiprazole API Market Size (2018-2029) & (US$ Million)
Figure 14. Global Aripiprazole API Sales (2018-2029) & (K Units)
Figure 15. Global Aripiprazole API Average Price (US$/Unit) & (2018-2029)
Figure 16. Aripiprazole API Report Years Considered
Figure 17. Aripiprazole API Sales Share by Manufacturers in 2022
Figure 18. Global Aripiprazole API Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Aripiprazole API Players: Market Share by Revenue in 2022
Figure 20. Aripiprazole API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Aripiprazole API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Aripiprazole API Sales Market Share by Country (2018-2029)
Figure 23. North America Aripiprazole API Revenue Market Share by Country (2018-2029)
Figure 24. United States Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Aripiprazole API Sales Market Share by Country (2018-2029)
Figure 27. Europe Aripiprazole API Revenue Market Share by Country (2018-2029)
Figure 28. Germany Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Aripiprazole API Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Aripiprazole API Revenue Market Share by Region (2018-2029)
Figure 35. China Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Aripiprazole API Sales Market Share by Country (2018-2029)
Figure 45. Latin America Aripiprazole API Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Aripiprazole API Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Aripiprazole API Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Aripiprazole API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Aripiprazole API by Type (2018-2029)
Figure 56. Global Revenue Market Share of Aripiprazole API by Type (2018-2029)
Figure 57. Global Aripiprazole API Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Aripiprazole API by Application (2018-2029)
Figure 59. Global Revenue Market Share of Aripiprazole API by Application (2018-2029)
Figure 60. Global Aripiprazole API Price (US$/Unit) by Application (2018-2029)
Figure 61. Aripiprazole API Value Chain
Figure 62. Aripiprazole API Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医薬品用アリピプラゾールのグローバル市場2023：純度≧99%、純度<99%
  • 医薬品用ポンプの世界市場2023年：縦型、横型
  • ボルチオキセチン臭化水素酸塩錠の世界市場2023年：5mg、10mg、20mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8680 )"アリピプラゾールAPIの世界市場2023年：純度≧99%、純度＜99%" (英文：Global Aripiprazole API Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。